The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

London stocks clock weekly gains; defensive shares rise

Fri, 13th May 2022 15:55

May 13 (Reuters) - Britain's FTSE 100 rallied on Friday to erase weekly losses, aided by gains in defensive stocks, although concerns over stubborn inflation and economic slowdown kept sentiment in check.

The blue-chip FTSE 100 added 2.6%, while the domestically focused mid-cap index advanced 2.3% and ended the week about 0.5% higher.

Banks and defensive sectors including consumer staples and healthcare stocks that tend to be less sensitive to the economic climate boosted the benchmark index.

Banks gained 3.1%, recouping their previous session's losses, while pharmaceutical giants such as AstraZeneca and GlaxoSmithKline and cyclical names Diageo, Unilever rose between 1.5% and 2.7%.

"Healthcare is seen as a more defensive sector, certainly with the ongoing pandemic. The demand for healthcare isn't going to go away, so you're seeing resilience there," said Susannah Streeter, senior investment and markets analyst, Hargreaves Lansdown.

Oil majors Shell and BP gained 2.8% and 3.6% respectively, tracking a rebound in crude prices.

After falling as much as 2.9%, the benchmark index recouped losses towards the end of a volatile week to end about 0.4% higher, as a relief rally led by the defensive stocks offset weakness in resource-linked shares amid recession fears and demand concerns.

Tension between Britain and the European Union over post-Brexit trade rules for Northern Ireland also added to investor woes.

"There is concern that if there isn't some kind of deal reached, there could be a fresh trade spat emerging between the EU and the UK that could lead to a further increase in prices," said Streeter.

Sage Group rose 3.9%, after the software company's first-half profit met market estimates and said its margin was expected to trend higher in the second half and beyond.

Related Shares

More News
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

5 Jun 2024 09:27

AstraZeneca completes USD2.4 billion Fusion Pharmaceuticals purchase

(Alliance News) - AstraZeneca PLC on Wednesday said it successfully completed the acquisition of Boston, Massachusetts-based Fusion Pharmaceuticals In...

3 Jun 2024 08:59

AstraZeneca cancer treatment Tagrisso recommended for approval in EU

(Alliance News) - AstraZeneca PLC said that, following further positive findings in clinical trial, Tagrisso has been recommended for use in the Europ...

3 Jun 2024 07:28

AstraZeneca's lung cancer treatment recommended for approval in EU

(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommend...

2 Jun 2024 20:03

Astra's Enhertu breast cancer trial shows 'unprecedented' results

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu slows the progression of breast cancer by about five months in women whose disease worse...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.